Lunit develops state-of-the-art AI-powered medical image analysis software, led by a team of 300+ people, including 70+ researchers, 10+ MDs, and 6 oncologists/pathologists.
Our highly skilled team consistently publishes in prestigious journals such as the Journal of Clinical Oncology, Clinical Cancer Research, JITC, NPJ, Precision Oncology, and more.
Our AI-powered multimodal analysis unlocks advances in oncology research and clinical practice.
Lunit SCOPE IO enables comprehensive tumor microenvironment assessment through quantitative immune phenotyping and beyond, facilitating faster and more accurate biomarker identification.
Lunit SCOPE uIHC offers quantification and feature scoring IHC analysis across tissue types, for any suite of IHC markers.
Lunit SCOPE GP predicts genotype modalities, offering insights into specific gene expression, mutations, and more, directly from H&E images.
Lunit technology optimizes clinical trial processes, powering PD-L1 scoring for Guardant Health's Galaxy PD-L1 tissue testing.
Lunit collaborates globally to advance oncology therapeutic biomarkers, driven by the company’s commitment to innovation and excellence.
Company Details
- Employees
- 44
- Founded
- -
- Industry
- Software Development
- NAICS
-
Software Publishers
- Keywords
- Stratipath.
Lunit Oncology Questions
Lunit Oncology's website is https://www.lunit.io/en/products/io
Lunit Oncology's LinkedIn profile is https://www.linkedin.com/company/lunitoncology
Lunit Oncology has
44 employees.
View email and phone details for 44
employees at Lunit Oncology.
Lunit Oncology's industry is
Software Development
Lunit Oncology's top competitors are
Volpara Health,
Sonrai,
Vuno Inc.,
Diadeep,
Stratipath,
Qritive,
Owkin,
Deep Bio Inc.,
Lunit Cancer Screening,
Mindpeak Gmbh.
Lunit Oncology's categories are Software Development
Lunit Oncology's founding year is 2013
